Epimedium's reputation and its actual human evidence base are two different things worth separating clearly.
Icariin, Epimedium's active compound, has been studied for effects on nitric oxide signalling and vasodilation — but human evidence remains limited, with most encouraging results coming from laboratory and animal work.
What matters most for this specific ingredient is the icariin percentage of the extract used — a detail that isn't stated for this formula, making the ingredient harder to evaluate than its name alone suggests.
60-day money-back guarantee, per the manufacturer.